Home/Mutagentech/Chris Bradley
CB

Chris Bradley

CEO & Co-Founder

Mutagentech

Therapeutic Areas

Mutagentech Pipeline

DrugIndicationPhase
SMM-SNV (Whole Genome)Research: Somatic/Germline Mutation DetectionService
SMM-SV (Whole Genome)Research: Structural Variant DetectionService
SMM-SNV ExomeResearch: Exome Mutation DetectionService
SMM-SNV Targeted PanelsResearch: Custom Panel SequencingService